APOE and cardiovascular disorder: Results remained similar after further adjustment for APOE ɛ4 status or prevalence of cardiovascular disease at metabolomics assessment, while adjustment for APOE ɛ4 status attenuated some associations more than adjustment for cardiovascular disease (Fig. 2).